Antigenic polypeptide usable as therapeutic agent for malignant neoplasm
US8323657B2 · kind B2 · utility
78Cited by
6References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 2, 2007 |
| Grant date | Dec 4, 2012 |
| Priority date | — |
| Expiry date | Apr 12, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a new tumor antigen having an epitope that induces a Th1 cell (a CD4-positive T cell specific to MAGE-A4), and a method ot application thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.